Hospital/Health-System Pharmacy

Here's what docs don't know about diabetes patientsSurveys conducted by the AACE with support from Sanofi US, identified differences in perceptions among adults living with type 2 diabetes. What healthcare professionals don't know may surprise you.
HHS tackles opioid epidemicHHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. Find out the policy changes.
Antibiotic stewardship programs: 4 case studiesAll antibiotic use has the potential to contribute to the development of antibiotic resistance. That’s why it is key to reduce inappropriate antibiotic use in order to slow the growth of resistance.

How health plans can derail ER care costsThe ER Savings Initiative is designed to deliver care in a hybrid model that collaborates with health systems to eliminate the unnecessary use and costs of their ERs.
New agreement supports value-based pharma contractingIndustry experts are using their proprietary data/analysis to help structure contracts between pharmaceutical companies and plans.
Four critical components for successful, value-based pharma contractsDespite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction.

Will price impede recently approved implant for opioid addicts?Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way.
Proposed Medicare Part B rule would cut payments for some drugsNew analysis finds proposed Medicare payment changes for physician-administered drugs would reduce reimbursement for those that cost more than $480 per day in 2016. Seven of the 10 drugs that constitute the largest reduction in reimbursement are used to treat cancer.
Shaping specialty pharmacy’s future: 4 perspectivesAt AMCP, four stakeholders representing the specialty pharmacy perspective, manufacturer perspective, payer perspective, and PBM perspective shared their thoughts on the future of specialty pharmacy.
AMCP Annual Meeting highlights specialty pharmaceutical challengesThe CEO of the Academy of Managed Care Pharmacy identifies key challenges and opportunities that will be discussed at the annual meeting.